Multi-institutional Outcomes for Simultaneous and Staged Urinary and Fecal Diversions in Patients Without Cancer - 02/08/18
, Yahir Santiago-Lastra b, Jeremy B. Myers c, Piyush Pathak c, Sean P. Elliott d, Katherine J. Cotter d, John T. Stoffel afor
The Neurogenic Bladder Research Group
Abstract |
Objective |
To compare the morbidity and postoperative recovery between patients treated with urinary diversion after colostomy with patients undergoing simultaneous double diversion (DD).
Methods |
A multi-institutional retrospective review was performed in patients treated with urinary diversion after colostomy or simultaneous DD between 2007 and 2014 for noncancerous indications. The Clavien-Dindo system was used to classify complications occurring within 90 days of surgery, and high-grade adverse events (HGAE) were classified grade 3 or higher.
Results |
A total of 46 patients were identified with fecal and urinary diversions (19 in the after colostomy (AC) group, 27 in the DD group). Common indications for urinary diversion were neurogenic bladder (54%) and urinary fistula (44%). Mean hospital stay and return of bowel function after surgery for entire cohort was 13 and 7 days, respectively, with no differences between AC and DD groups. Almost 50% of patients in the cohort experienced an HGAE but there was no difference in HGAE incidence (8/19 AC, 13/27 DD; P = .69) or complication type between the groups. Increased operative time (5% risk per every 15 minutes over 7 hours, P = .03) was the only independent variable associated with increased risk of HGAE. DD was not independently associated with increased risk of HGAE compared with staged urinary diversion.
Conclusion |
Morbidity and postoperative recovery appeared similar whether urinary diversion is performed after colostomy or during a DD.
Le texte complet de cet article est disponible en PDF.Plan
| Financial Disclosure: Paholo G. Barboglio Romo is a co-investigator for Ipsen. Jeremy B. Myers receives salary support from Patient-Centered Outcomes Research Institute (CER14092138) and from the Department of Defense, grant SCI170051. These grants are focused on spinal cord injury patients and use patient-reported outcomes. Sean P. Elliott receives salary support from Patient-Centered Outcomes Research Institute (CER14092138) and from the Department of Defense, grant SCI170051. These grants are focused on spinal cord injury patients and use patient-reported outcomes. John Stoffel is a principal investigator for Ipsen study. He receives salary support from Patient-Centered Outcomes Research Institute (CER14092138) and from the Department of Defense, grant SCI170051. These grants are focused on spinal cord injury patients and use patient-reported outcomes. Yahir Santiago-Lastra, Piyush Pathak, and Katherine Cotter declare that they have no relevant financial interests. |
|
| Funding Support: This study was self-funded. |
Vol 118
P. 202-207 - août 2018 Retour au numéro
Article précédent
- Giant Renal Hemangioma in an Adolescent Girl: A Very Rare Entity
- Tayfun Oktar, M. Irfan Donmez, Zuhal Bayramoglu, Yasemin Ozluk, Ozge Tepe, Isin Kilicaslan, Ibrahim Adaletli, Haluk Ander
- Editorial Comment
- Justin S. Han
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?